Research On The Influence Of Human Capital On Enterprise Performance

Since the outbreak of COVID-19,the national demand for pharmaceutical products has surged,forcing pharmaceutical companies to put higher requirements on product research and development technology,while product innovation and research and development are inseparable from high-quality talents.Talent is an important strategic resource to realize sustainable development and win competitive advantage.Human capital is the sum of knowledge,labor,skills and other elements of talents,which complement and promote enterprise development.Generally speaking,the level of human capital affects the management level of an enterprise,and the economic benefit of an enterprise plays a role in the investment and accumulation of talents.With the intensification of competition among enterprises,more and more high-tech enterprises begin to strengthen the investment of human capital,and effectively improve the added value of technological products and enterprise performance level.As a representative of high-tech enterprises,human capital plays an important role in medical manufacturing industry.Paper is written in a pharmaceutical manufacturing enterprise human capital and enterprise performance as the research object,based on the actual situation of our country medicine manufacturing enterprise to carry on the empirical research,and from the Angle of human capital to explore how to improve the business performance of pharmaceutical enterprises in China,so as to improve the pharmaceutical enterprise human capital utilization efficiency and management level of human capital,the purpose of Help pharmaceutical manufacturing enterprises out of the human capital dilemma.Firstly,this paper summarizes the research results on the relationship between human capital and enterprise performance at home and abroad,and measures the human capital index from three perspectives of human capital stock,human capital investment and human capital flow.On this basis,the relationship model between human capital and enterprise performance is constructed.Then,the panel data of 129 listed pharmaceutical manufacturers from 2016 to 2020 are selected as samples,and correlation analysis and regression analysis are used to conduct empirical research on the sample data.First carries on the regression analysis of pharmaceutical manufacturing enterprises of all samples,and then to different enterprise nature and regional heterogeneity analysis,according to the nature of the enterprise pharmaceutical manufacturing enterprises can be divided into state-owned enterprises and private enterprises,according to the level of economic development pharmaceutical manufacturing enterprise area can be divided into the eastern,central and western areas.The final research results show that :(1)overall,human capital of pharmaceutical manufacturing enterprises has a relatively good impact on corporate performance.In addition to employee salary investment,other human capital indicators have a significant impact on corporate performance,which promotes the improvement of corporate performance.(2)from the Angle of enterprise nature of the heterogeneity,the role of human capital in enterprise performance of the state-owned enterprise than private enterprise,state-owned enterprise employee wages compensation investment for its corporate performance is not ideal,the influence of the private enterprise’s human capital stock,the staff salary compensation investment and human capital turnover is not significant effect on performance.(3)According to the regional heterogeneity analysis,the human capital of pharmaceutical manufacturing enterprises in the eastern region has a lag effect on enterprise performance,the human capital of pharmaceutical manufacturing enterprises in the western region has a better impact on enterprise performance,and the human capital of enterprises in the central region has a two-year lag effect on enterprise performance.